Bacteria: How Legionella defend their turf
Communities of bacteria that cause Legionnaire’s disease repel other bacteria by secreting an acid called HGA.
- University of Michigan Medical School, United States
Legionella pneumophila is a water-borne bacterium that takes up residence in engineered water systems, and if inhaled by susceptible people, it can cause a severe form of pneumonia known as Legionnaires’ disease. According to the Centers for Disease Control and Prevention, L. pneumophila infections are on the rise and are now the leading cause of water-associated illness in the United States. However, a major problem is that decontamination methods often fail to eradicate every single bacterium, which allows populations of bacteria to build up again (Cervero-Aragó et al., 2015; Berjeaud et al., 2016).
One way that Legionella manages to persist in the environment is by associating with biofilms – microbial communities that attach to surfaces and encase themselves in a protective matrix (Abu Khweek and Amer, 2018). The microbes in these communities engage in behaviors that mutually benefit each other, such as forming food chains or making up the sugar chains of the biofilm’s protective shield (Elias and Banin, 2012). Inhabitants of the biofilm must also repel other microbes that are unlikely to contribute to the community (Drescher et al., 2014; Özkaya et al., 2017). However, despite these biofilms being a threatening pool of infectious bacteria, little is known about how L. pneumophila socially behave. Now, in eLife, Tera Levin, Brian Goldspiel and Harmit Malik from the Fred Hutchinson Cancer Research Center report how highly dense populations of L. pneumophila can inhibit the growth of other bacteria belonging to the same or related species of Legionella (Levin et al., 2019).
Levin et al. found that L. pneumophila secrete a molecule called homogenetisic acid, or HGA for short, which is produced by the amino acids tyrosine and phenylalanine as they convert into more complex molecules. Legionella primarily secretes HGA after the bacteria have stopped replicating, during a period known as the stationary phase. Once secreted, HGA combines with oxygen and self-assembles into long chains to form a dark brown pigment. This pigment, called pyomelanin, is known to protect Legionella against light damage and to help them acquire iron, which is an essential micronutrient (Steinert et al., 1995; Zheng et al., 2013). Levin et al. show that HGA also has toxic properties that can defend Legionella communities from invading microbes.
These properties became evident when the researchers discovered that L. pneumophila mutants that fail to inhibit the growth of other Legionella bacteria did not produce HGA. Interestingly, secreted HGA is only toxic if oxygen is present in the environment, and Levin et al. argue that a reactive intermediate formed during the conversion of HGA to pyomelanin likely accounts for its inhibitory properties. HGA is also detoxified by reducing agents, including the amino acid cysteine, which must be present for L. pneumophila to grow in laboratory cultures.
One conundrum is how L. pneumophila avoids the toxic effects of HGA. As secretion of the inhibitor increases when the bacteria are in the stationary phase – a state typically associated with high bacterial density – Levin et al. speculated that genes involved in either quorum sensing (which leads to changes in gene regulation based on population density) or the stringent stress response may promote resistance to HGA. However, deleting known genes in each of these widespread cell-signaling pathways does not alter resistance or susceptibility to HGA. Instead, L. pneumophila cells are only susceptible to inhibition when at low density, regardless of whether they are in the stationary or replicating phase. It therefore remains to be discovered how individual L. pneumophila cells at high density protect themselves from HGA.
Thinking about the natural habitats of L. pneumophila, Levin et al. envision individual bacterial cells sticking to a surface, such as the interior of a water pipe (Figure 1). As L. pneumophila begin to replicate, they form a small colony, then grow to form a large cooperative community, likely sharing resources liberated by digestive enzymes that they have secreted (White and Cianciotto, 2019). After reaching a certain density, the residents protect their turf from other bacteria by releasing a pulse of HGA. Since the high concentration of bacteria in the colony also triggers resistance to HGA, the community is automatically protected from the inhibitor.
Figure 1
High-density colonies of Legionella protect themselves by secreting pulses of HGA.
The development of Legionella colonies begins with individual cells adhering to a surface, such as the inside of a water pipe. After reaching a certain density, the bacteria intensify the secretion of HGA, which prevents other Legionella cells from joining the colony. Image credit: Elisa D. Hughes (CC BY 4.0).
The work of Levin, Goldspiel and Malik provides an important insight into how Legionella persist within microbial communities, and also identifies several questions that warrant further investigation. First, as biofilms comprised of a single species are not common in nature (Elias and Banin, 2012), it would be useful to know more about the impact of HGA on non-Legionella bacteria. In addition, understanding how the reactive intermediate of HGA is able to inhibit Legionella, and how individuals within dense colonies of the pathogen acquire resistance, could significantly advance the broad field of microbiology ecology. Finally, it is tempting to speculate that the HGA inhibition and resistance pathways discovered by Levin et al. could help identify new ways of eliminating pathogenic Legionella from engineered water systems.
References
-
Factors mediating environmental biofilm formation by Legionella pneumophilaFrontiers in Cellular and Infection Microbiology 8:38.https://doi.org/10.3389/fcimb.2018.00038
-
Multi-species biofilms: living with friendly neighborsFEMS Microbiology Reviews 36:990–1004.https://doi.org/10.1111/j.1574-6976.2012.00325.x
-
Maintenance of microbial cooperation mediated by public goods in single- and multiple-trait scenariosJournal of Bacteriology 199:00297-17.https://doi.org/10.1128/JB.00297-17
-
The lly protein protects Legionella pneumophila from light but does not directly influence its intracellular survival in Hartmannella vermiformisApplied and Environmental Microbiology 61:2428–2430.
Article and author information
Author details
Publication history
Copyright
© 2019, Hughes and Swanson
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,077
- views
-
- 103
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Bacteria: How Legionella defend their turf
eLife 8:e48695.
https://doi.org/10.7554/eLife.48695
Further reading
-
- Immunology and Inflammation
- Microbiology and Infectious Disease
Innate immune responses triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection play pivotal roles in the pathogenesis of COVID-19, while host factors including proinflammatory cytokines are critical for viral containment. By utilizing quantitative and qualitative models, we discovered that soluble factors secreted by human monocytes potently inhibit SARS-CoV-2-induced cell-cell fusion in viral-infected cells. Through cytokine screening, we identified that interleukin-1β (IL-1β), a key mediator of inflammation, inhibits syncytia formation mediated by various SARS-CoV-2 strains. Mechanistically, IL-1β activates RhoA/ROCK signaling through a non-canonical IL-1 receptor-dependent pathway, which drives the enrichment of actin bundles at the cell-cell junctions, thus prevents syncytia formation. Notably, in vivo infection experiments in mice confirmed that IL-1β significantly restricted SARS-CoV-2 spread in the lung epithelium. Together, by revealing the function and underlying mechanism of IL-1β on SARS-CoV-2-induced cell-cell fusion, our study highlights an unprecedented antiviral function for cytokines during viral infection.
-
- Microbiology and Infectious Disease
mRNA vaccines against SARS-CoV-2 were rapidly developed and were effective during the pandemic. However, some limitations remain to be resolved, such as the short-lived induced immune response and certain adverse effects. Therefore, there is an urgent need to develop new vaccines that address these issues. While live-attenuated vaccines are a highly effective modality, they pose a risk of adverse effects, including virulence reversion. In the current study, we constructed a live-attenuated vaccine candidate, BK2102, combining naturally occurring virulence-attenuating mutations in the NSP14, NSP1, spike, and ORF7-8 coding regions. Intranasal inoculation with BK2102 induced humoral and cellular immune responses in Syrian hamsters without apparent tissue damage in the lungs, leading to protection against a SARS-CoV-2 D614G and an Omicron BA.5 strains. The neutralizing antibodies induced by BK2102 persisted for up to 364 days, which indicated that they confer long-term protection against infection. Furthermore, we confirmed the safety of BK2102 using transgenic (Tg) mice expressing human ACE2 (hACE2) that are highly susceptible to SARS-CoV-2. BK2102 did not kill the Tg mice, even when virus was administered at a dose of 106 plaque-forming units (PFUs), while 102 PFU of the D614G strain or an attenuated strain lacking the furin cleavage site of the spike was sufficient to kill mice. These results suggest that BK2102 is a promising live-vaccine candidate strain that confers long-term protection without significant virulence.
